Josef Ecker “The Gut-Liver Connection: How The Gut Microbiota Regulates Host Lipid Metabolism”

Prof. Dr. Josef Ecker, born in 1978, is a distinguished biologist specializing in lipid metabolism and its implications for health and disease. He completed his biology studies at the University of Regensburg, earning his doctorate in 2007. Following his Ph.D., he conducted research at the University of California, Berkeley, focusing on lipid metabolism.

Currently, Prof. Ecker leads the Functional Lipidomics and Metabolism Research group at the Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg. His research centers on the interplay between dietary fats, gut microbiota, and systemic lipid metabolism, particularly concerning intestinal lipid absorption and its role in diseases such as cancer.

In addition to his role in Regensburg, Prof. Ecker is a principal investigator in the Collaborative Research Center (CRC) 1371 at the Technical University of Munich (TUM). Within this consortium, he co-leads Project P13, which investigates the impact of dietary fat and gut microbiota interactions on intestinal lipid absorption, systemic lipid metabolism, and intestinal cancer.

Prof. Ecker has an extensive publication record, with his work being cited over 3,500 times, reflecting his significant contributions to the field of lipidomics.

His research aims to elucidate the molecular mechanisms underlying lipid metabolism and its influence on health, providing insights that could lead to novel therapeutic strategies for metabolic diseases and cancer. Many thanks, Josef, for your great presentation!

Andreas Koeberle “Targeting ferroptosis and stress adaption: insights from functional multiomics”

Prof. Dr. Andreas Koeberle is a distinguished researcher specializing in the interface of inflammation, cancer, lipid metabolism, and signaling, focusing on uncovering the molecular mechanisms of natural products.

Since 2019, he has been the Head of the Michael Popp Institute at the University of Innsbruck, Austria, where he also holds the position of University Professor for new phyto entities.

He recently obtained a full professorship at the University of Graz in the Department of Pharmaceutical Sciences.

Prof. Koeberle has an extensive publication record, contributing significantly to biochemistry and pharmacology.

His research aims to develop novel therapeutic strategies by exploring the bioactivity of natural compounds, particularly in the context of inflammatory diseases and cancer.

We were grateful for Andreas’ insightful presentation on the link between the membrane lipidome and ferroptosis signaling. Thank you for coming to Vienna, Andreas!